Rare Disease 360°, Collaborative Strategies to leave no-one behind Proud to present the high potential of APTEEUS Protein Re-expression Therapy, Isabelle will attend the European Conference on Rare Diseases and Orphan Products in Vienne. SHe will also expose the innovative way APTEEUS and Les Petits MeCP2 association are collaborating.
Camille, Isabelle, Loïc, Simon, Benoit and Terence wish you all the best for 2018.
All the team wish you the best for this new year.
The first edition of Hibster is 120 brains in turmoil, 48h of thinking for unlimited creativity. One team will work on individualized medicine proposed by APTEEUS. Eager to see the result!
This is thanks to an innovative strategy of Individualized Medicine, that the pair of Pharmacists, Terence Beghyn and Benoit Deprez were awarded at the Concours Mondial de l’Innovation in the category “Individualized Medicine” the 18th of July. ID2STOP Orphan is the name given to the program and pushing to the extreme the principle of personalized..